THURSDAY, June 6, 2024 (HealthDay News) — Despite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger. The issue arose because weight-loss drugs slow gastric emptying. The thought was that food might linger in theContinue Reading
TUESDAY, June 4, 2024 (HealthDay News) — Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so. Researchers at Case Western Reserve University in Cleveland report that obese folks with drinking issues whoContinue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests. The active ingredient in the weight-loss medications, semaglutide, also appears to affect the way that the tongue and brain respond to sweet tastes,Continue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they feared theContinue Reading
FRIDAY, May 24, 2024 (HealthDay News) — Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the risk of severe kidney events, heart problems and death from any cause in patients whoContinue Reading
THURSDAY, May 23, 2024 (HealthDay News) — Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, OzempicContinue Reading
WEDNESDAY, May 22, 2024 (HealthDay News) — The number of American teens and young adults who’ve been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That’s compared to an overall decline of about 3% in young Americans’ use ofContinue Reading
TUESDAY, May 21, 2024 (HealthDay News) — You’ve watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely budges. Why? New researchContinue Reading
MONDAY, May 20, 2024 (HealthDay News) — New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some patients. “Although these drugs do work and should be used for the right reason, we just want toContinue Reading
FRIDAY, May 17, 2024 (HealthDay News) — The smell of food is appetizing when you’re hungry. At the same time, it can be a turnoff if you’re full. That’s due to the interaction between two different parts of the brain involving sense of smell and behavior motivation, a new studyContinue Reading